Ultragenyx Pharmaceutical | Należności Handlowe



Trade Debtors Zmiana Data
Acadia Pharmaceuticals USD 104.7M 5.67M 2024-12
Agios Pharmaceuticals USD 3.34M 765K 2025-03
Alnylam Pharmaceuticals USD 418.04M 12.73M 2025-03
BioMarin Pharmaceutical USD 739.18M 78.64M 2025-03
Insmed USD 52.01M 9.7M 2024-12
Ionis Pharmaceuticals USD 39.71M 52.48M 2025-03
Kyowa Hakko Kirin JPY 136.49B 20.52B 2025-03
MacroGenics USD 4.31M 4.44M 2024-12
Moderna USD 306M 286M 2025-03
Neurocrine Biosciences USD 479.1M 2M 2024-12
PTC Therapeutics USD 158.55M 41.42M 2024-12
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Sarepta Therapeutics USD 649.73M 133.74M 2024-12
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



Ultragenyx Pharmaceutical Należności Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.